Wells Fargo & Company Medical Devices

Wells Fargo & Company

$429 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
PACB Pacific Biosciences Of California, Inc.	$326M	$201,000 0.0% of portfolio	170,988	Q1 2025 Added 4.8%
NNOX Nano X Imaging Ltd.	$270M	$195,000 0.0% of portfolio	39,148	Q1 2025 Added 1.14%
ZIMV Zim Vie Inc.	$267M	$188,000 0.0% of portfolio	17,416	Q1 2025 Added 2.22%
MXCT Maxcyte, Inc.	$214M	$173,000 0.0% of portfolio	63,515	Q1 2025 Added 3.43%
CERS Cerus Corp	$244M	$146,000 0.0% of portfolio	105,148	Q1 2025 Added 2.05%
NVRO Nevro Corp	$207M	$130,000 0.0% of portfolio	22,307	Q1 2025 Added 3.3%
LUNG Pulmonx Corp	$119M	$128,000 0.0% of portfolio	19,132	Q1 2025 Added 3.88%
ANIK Anika Therapeutics, Inc.	$156M	$122,000 0.0% of portfolio	8,133	Q1 2025 Added 9.59%
CVRX Cv Rx, Inc.	$171M	$120,000 0.0% of portfolio	9,820	Q1 2025 Added 10.41%
VMD Viemed Healthcare, Inc.	$247M	$119,000 0.0% of portfolio	16,386	Q1 2025 Added 2.26%
RCEL Avita Medical, Inc.	$130M	$117,000 0.0% of portfolio	14,417	Q1 2025 Added 3.41%
ICAD Icad Inc	$98M	$111,000 0.0% of portfolio	54,349	Q1 2025 Added 37.45%
INGN Inogen Inc	$144M	$103,000 0.0% of portfolio	14,531	Q1 2025 Added 4.41%
BFLY Butterfly Network, Inc.	$325M	$91,000 0.0% of portfolio	40,203	Q1 2025 Added 170.93%
DCTH Delcath Systems, Inc.	$99.3M	$65,000 0.0% of portfolio	5,164	Q1 2025 Added 243.58%
MASS 908 Devices Inc.	$220M	$62,000 0.0% of portfolio	14,019	Q1 2025 Added 2.27%
QIPT Quipt Home Medical Corp.	$71.5M	$51,000 0.0% of portfolio	22,055	Q1 2025 Reduced 7.53%
SGHT Sight Sciences, Inc.	$164M	$40,000 0.0% of portfolio	16,975	Q1 2025 Added 2.26%
PROF Profound Medical Corp.	$116M	$27,000 0.0% of portfolio	4,784	Q1 2024 Added 41.92%
ELMD Electromed, Inc.	$161M	$26,000 0.0% of portfolio	1,100	Q1 2025 Added 57.14%
SENS Senseonics Holdings, Inc.	$270M	$20,000 0.0% of portfolio	30,977	Q3 2024 Reduced 67.84%
LNSR Lensar, Inc.	$146M	$7,000 0.0% of portfolio	556	Q1 2025 Added 194.18%
EDAP Edap Tms Sa	$54.6M	$6,000 0.0% of portfolio	3,500	Q1 2020 New
NVNO En V Veno Medical Corp	$47.3M	$5,000 0.0% of portfolio	2,002	Q1 2025 Added 0.1%
LUCD Lucid Diagnostics Inc.	$42.4M	$3,000 0.0% of portfolio	2,150	Q1 2025 Reduced 6.52%
AZYO Aziyo Biologics, Inc.	$13.5M	$2,000 0.0% of portfolio	1,500	Q1 2025 Added 200.0%
HYPR Hyperfine, Inc.	$53.9M	$1,000 0.0% of portfolio	2,581	Q4 2024 New
IINN Inspira Technologies Oxy B.H.N. LTD	$16.5M	$1,000 0.0% of portfolio	2,050	Q4 2024 New
NMTC Neuroone Medical Technologies Corp	$12.6M	$1,000 0.0% of portfolio	1,333	Q1 2025 Added 300.3%
NXL Nexalin Technology, Inc.	$6.99M	$1,000 0.0% of portfolio	600	Q4 2024 New
BIO-B Bio Rad Laboratories, Inc.	$11.2B	$0 0.0% of portfolio	-	Q2 2023 Added 203.57%
BWAY Brainsway Ltd.	$198M	$0 0.0% of portfolio	5	Q1 2025 Reduced 92.86%
CLPT Clear Point Neuro, Inc.	$269M	$0 0.0% of portfolio	69	Q3 2024 Added 176.0%
CODX Co Diagnostics, Inc.	$9.46M	$0 0.0% of portfolio	275	Q1 2025 Reduced 76.6%
CTSO Cytosorbents Corp	$45.8M	$0 0.0% of portfolio	250	Q3 2024 Reduced 44.81%
FONR Fonar Corp	$105M	$0 0.0% of portfolio	13	Q4 2024 Reduced 7.14%
SRTS Sensus Healthcare, Inc.	$77.2M	$0 0.0% of portfolio	1	Q1 2025 New
XTNT Xtant Medical Holdings, Inc.	$70.3M	$0 0.0% of portfolio	1	Q2 2024 Reduced 99.73%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.